Here are four things to know about the ASC company’s stock.
1. AmSurg shares outperformed the S&P 500 by 16.37 percent in the past week, according to the report.
2. The 50-day moving average of the stock is $71.54, and the 200-day moving average is $64.80.
3. On Aug. 5 the company shares hit a one-year high of $85.52. The stock’s one-year low is $47.68.
4. Five analysts have given AmSurg stock a “strong buy” rating. Six analysts set a “buy rating.” Just one analyst rates the company’s stock as “underperforming,” according to the report.
More articles on transactions and valuation issues:
6 hospital & health systems opening ASCs – August 11, 2015
28 ASC joint ventures & acquisitions in 2015 so far
6 recent ASC acquisitions & partnerships – Aug. 6, 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
